Screening of Donated Blood for Transfusion Transmitted Infections by Serology and Response Rate to Notification of Reactive Results: A Tertiary Care Institutional Experience

  • Rohit Vasantbhai Bhalara Department of Pathology, Pandit Dindayal Upadhyay Medical College, Rajkot
  • Payal Shah Department of Pathology, Pandit Dindayal Upadhyay Medical College, Rajkot
  • Ravi Kiritkumar Kothari Department of Pathology, Pandit Dindayal Upadhyay Medical College, Rajkot
  • Gauravi Dhruva Department of Pathology, Pandit Dindayal Upadhyay Medical College, Rajkot
Keywords: Blood donor counselling, TTI notification, ELISA


Background: Safety for blood Transfusion begins with healthy donors. A basic part of preventing transfusion transmitted infections (TTIs) is to notify and counsel reactive donors. This study analysed trends in the prevalence of transfusion-transmissible infectious pathogens among blood donors and notify them as well as to assess response rate among them. Donor notification and counselling protect the health of the donor and stop secondary transmission of infectious diseases. Methods: 38707 blood donations were screened for TTIs, namely, HIV, HBV, HCV, and syphilis, Malarial Parasite by serology. ELISA testing for anti-HIV antibody, anti-HCV antibody and HBsAg and RPR test for syphilis, Rapid card test for Malarial Parasite. All reactive donors were retested in duplicate and notified of their status by communicating through telephone.  Result: We evaluated 341 (0.88%) cases with reactive screening test results (0.617% HBV, 0.016% HCV, 0.134% HIV, 0.08% syphilis, 0.031% Malaria ). Only 179 donors (52.5%) responded to notification. The response among voluntary donors was better as compared to the replacement donors (54.1 % versus 40.7 %). Only 101 (57.22%) responsive donors followed their first attendance at referral clinic.  Conclusion: Our study provides prevalence rate of TTIs among blood donors and importance of proper donor counselling and notification of TTI status to all reactive donors who opt to receive this information.


Leena M S,Mohd S. Trend and prevalence of transfusion transmitted infections among blood donors in rural teaching institute, South India. J Pathol Nepal.2012;2:203–206.

Fessehaye F, Naik D, Fessehaye T.Transfusion transmitted infections—a retrospective analysis from the National Blood Transfusion Service in Eritrea.Pan Afr Med J.2011;9:40.

Buseri F I,Muhibi M A, Jeremiah Z A. Seroepidemiology of transfusion transmissible infectious diseases among blood donors in Osogbo, south west Nigeria.Blood Transfus. 2009;7:293–299.

Z. S. Bharucha, “Safe blood transfusion practices,” Indian Journal of Pediatrics, vol.68,no.2,pp.127–131,2001.

R. Hans and N. Marwaha, “Nucleic acid testing-benefits and constraints,” Asian Journal of Transfusion Science, vol. 8, no. 1, pp.2–3,2014.

F. Bihl, D. Castelli, F. Marincola, R. Y. Dodd, and C. Brander, “Transfusion-transmitted infections,” Journal of Translational Medicine,vol.5,article25,2007.

D.P.Patel, D.S.Patel, D.J.Bhatt, D.N.Bhatnagar,and D.M.G. Shah,“Evaluation of response to donor notification of reactive transfusion transmitted infections(ttis)result,”National Journal of Integrated Research in Medicine,vol.3,no.2,pp.20–25,2012

Choudhury L P, Tetali S. Ethical challenges in voluntary blood donation in Kerala, India. J Med Ethics 2007;33: 140-2.

L.A.Bashawri,“Are view of predonation blood donor deferrals in a university hospital,” Journal of Family and Community Medicine,vol.12,no.2,pp.79–84,2005.

K. A. Munsterman, A. J. Grindon, M. T. Sullivan et al., “Assessment of motivations for return donation among deferred blood donors,”Transfusion,vol. 38, no.1,pp.45–50,1998.

Global blood safety and availability. Key facts and figures, 2010.

P.KaurandS.Basu,“Transfusion transmitted infections: existing and emerging pathogens,”Journal of Postgraduate Medicine , vol.51,no.2,pp.146–151,2005.

D.Arora,B.Arora, and A.Khetarpal,“Seroprevalence of HIV, HBV,HCV and syphilis in blood donors in Southern Haryana,” Indian Journal of Pathology and Microbiology,vol.53,no.2,pp. 308–309,2010.

P. Pallavi, C. K. Ganesh, K. Jayashree, and G. V. Manjunath, “Seroprevalence and trends in transfusion transmitted infections among blood donors in a University Hospital blood bank: a 5 year study,” Indian Journal of Hematology and Blood Transfusion,vol.27,no.1,pp.1–6,2011.

K. Chatterjee, P. Coshic, M. Borgohain, R. M. Thapliyal, S. Chakroborty, and S. Sunder, “Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis b and c viruses in a tertiary care hospital,”National Medical Journal of India,vol.25,no.4,pp.207–209,2012.

T.Chandra, S.N.F.Rizvi,and D.Agarwal,“Decreasing prevalence of transfusion transmitted infection in Indian scenario,” The Scientific World Journal, vol. 2014, Article ID 173939, 4 pages,2014.

M. Meena, T. Jindal, and A. Hazarika, “Prevalence of hepatitis B virus and hepatitis virus among blood donors at tertiary care hospital in India: a five-year study,”Transfusion, vol.51, no. 1,pp. 198–202,2011.

C. Bianco and D. Kessler, “Donor notification and counselling management of blood donors with positive test results,” Vox Sanguinis,vol.67,no.3,pp.255–259,1994

N.Agarwal,“Response rate of blood donors in the uttarakhand region of india after notification of reactive test results on their blood samples,” Blood Transfusion, vol. 12, no. 1, pp. s51–s53, 2014.

S. Dontula, A. Mathur, T. Kamaladoss, S. Adimurthy, and L. Jagannathan, “Donor disclosure—a donor’s right and blood bank’s responsibility,” Transfusion Alternatives in Transfusion Medicine, vol. 12, no.3-4,pp. 44–50,2012.

N. Choudhury, P. Singh, and H. Chandra, “AIDS awareness in blood donors in northIndia,”Transfusion Medicine,vol. 5, no. 4,pp.267–271,1995.

S. Kleinman, B. Wang, Y. Wu et al., “The donor notification process from the donor’s perspective,”Transfusion,vol.44,no. 5,pp.658–666,2004

Original Article